Cytochrome P450 represent a superfamily of heme proteins that play a critical role in the oxidative metabolism of xenobiotics and endogenous substances, and there are several isoforms. The human CYP3A subfamily contains mainly three isoforms, CYP3A4, CYP3A5, and CYP3A7.
CYP3A4 is a major isoform that accounts for about 30% of the amount of total CYP in human adult livers and is responsible for approximately 50% of the metabolism by CYPs of known drugs in humans. 4, 5) CYP3A5 is expressed polymorphically throughout development in the liver. 6, 7) CYP3A7 is a major CYP isoform in the human fetal and newborn liver. 8) It is known that the human placenta contains multiple CYP isoforms in the mitochondria and endoplasmic reticulum of trophoblastic cells. 9) The type and amount of expressed CYPs varies depending on the period of gestation and maternal health status. 10, 11) In general, it appears that the placenta expresses a wider variety of CYP isoforms in the first trimester than at term. 12, 13) Thus it has been suggested that xenobiotic metabolism in the placenta may be feto-protective during the critical embryogenic and organogenesis stage prior to the second trimester, when it is most susceptible to the effects of teratogens, the expression of CYP mRNAs is maximal. 14) However, the central nervous system develops throughout the pregnancy and may also be affected in the later stages of pregnancy. Even though, as described above, various studies of enzymes related to pharmacokinetics in human placenta have been reported, there is only limited research in fetal membranes. The fetal membranes, which extend from the placenta, are an important barrier between the fetus and mother. The membranous structure that surrounds the developing fetus and forms the amniotic cavity is derived from fetal tissue except for decidua and is composed of three layers: amnion (inner layer), chorion leave (middle layer) and decidua (outer layer). The amnion is a translucent structure adjacent to the amniotic fluid. The chorion leave is a more opaque membrane that is attached to the decidua (i.e., maternal tissue that lines the uterus during pregnancy). The amnion and chorion leave are separated by the exocelomic cavity until approximately three months gestation, when they become fused. These membranes regulate the access of substances including drugs and other harmful chemicals to and from the amniotic fluid and, hence, the fetus. 15) In recent years, it has been reported that the multidrug resistance/P-glycoprotein gene (MDR1/P-gp) and breast cancer resistance protein (BCRP), belong to the ATP-binding cassette transporter family are expressed in human fetal membranes including decidua. 16, 17) It is considered that the role of these transporters is to discharge drugs in amniotic fluid and to keep out transfer of drugs from the maternal side via the uterus. It is well established that P-glycoprotein transports many drugs that are metabolized by CYP3A4 and many modulators of P-glycoprotein also modulate the CYP3A gene family. 18) To the best of our knowledge, the expression of CYP3A isoforms in the fetal membranes, however, has not been investigated, even at the mRNA level. Furthermore, the CYP3A mRNAs and proteins have been detected from placenta, 10, 19, 20) but thus far no study describing steroid 6b-hydroxylation, erythromycin or dextromethorphan N-demethylation or any other relevant marker activities for CYP3A isoforms in human placenta has been published. 13, 21) In the present study, we investigated the expression of CYP3As in human fetal membranes and placenta at term, by use of quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR), Western blot analysis and testosterone 6b-hydroxylation. Tissue Preparation Fetal membrane and placental tissues were obtained under a protocol approved by the Ethics Committee of Shinshu University School of Medicine after term normal delivery or Caesarean section (33-42 weeks) from Shinshu University Hospital. Smoking status was assessed by patient interview. Fetal membranes were split into amnion and chorion leave attached decidua (chorion/decidua) in the mesenchymal layer, which is located between the amnion epithelium and the chorion leave trophoblast. The amnion and chorion/decidua contained a part of the mesenchymal layer. Tissues for analyses of testosterone 6b-hydroxylation and Western blotting were stored at Ϫ150°C until the homogenate preparation. A portion of tissue was dipped in RNAlater and stored at -150°C until extraction of total RNA.
MATERIALS AND METHODS

Materials
RNA Extraction and Reverse Transcription Reaction Total RNA was extracted from tissue (30-50 mg) dipped in RNAlater using illustra RNAspin Mini kit according to the manufacturer's instructions. First-strand cDNA was generated from 4 mg of total RNA. Reverse transcription reaction was performed using a SuperScript III First-Strand Synthesis System for RT-PCR in accordance with the manufacturer's instruction.
Real-Time RT-PCR Analysis For detection of expression levels, CYP mRNAs were analyzed by SYBR Green real-time quantitative RT-PCR. The levels of these mRNAs were normalized relative to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. All PCR procedures were performed using the ABI 7500 Fast System SDS software version 1.3.1 (Applied Biosystems, Foster City, CA, U.S.A.) according to each manufacturer's instructions. PCR was performed using diluted cDNA template in a 25 ml reaction mixture containing 0.30 mM of each primer and 12.5 ml SYBR Green real-time PCR Master Mix. The primers used are summarized in Table 1 .
Western Blotting Tissues (0.3-0.4 g) were homogenized in 1 ml of lysis buffer, according to the methods of Yeboah et al. 17) The protein concentration was measured using a DC protein assay kit using bovine serum albumin as a standard. Samples containing 1 mg protein were diluted in an equal volume of sample buffer and separated on 10% polyacrylamide gels by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as previously reported. 23, 24) SUPERSOMES expressed CYP3A7 (BD Genetest, Franklin Lakes, NJ, U.S.A.) was used as the reference standard. Western blotting analysis was carried out according to the method reported previously. 25) The proteins were transferred to Clear Blot Membrane-p by electrophoresis at 1 mA/cm 2 for 60 min. Non-specific binding was blocked overnight at 4°C with 2% ECL Advance Blocking Reagent in 20 mM Tris buffered saline (pH 7.6) containing 0.1% Tween-20. The membrane was incubated for 1 h at room temperature with an anti-CYP3A7 antibody. This was followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG polyclonal antibody. Proteins were visualized by chemiluminescence detection with an ECL system and Hyperfilm for ECL in accordance with the manufacturer's instruction.
Assay for Testosterone 6b b-Hydroxylase Activity Tissues, about 1 g, were homogenized in 3 ml of 10 mM Tris-HCl buffer (pH 7.5) containing 250 mM sucrose, 0.1 mM ethylenediaminetetraacetic acid (EDTA) and protease inhibitor. Tissue homogenates were added into 0.26 mM testosterone, 1 mM NADPH and 100 mM potassium phosphate buffer (pH 7.4) to a final volume of 0.5 ml. The mixture was incubated at 37°C for 3 h after preincubation at 37°C for 2 min. After incubation, 10 ml of 1 mM ethoxyresorufin was added to the reaction mixture as an internal standard and was vortex-mixed with 1.25 ml of ethyl acetate and centrifuged. Aliquots (1 ml) of organic phase were transferred to microcentrifuge tubes. Ethyl acetate was evaporated under nitrogen gas and the samples were dissolved with 100 ml of mixture of 10 mM ammonium acetate (98%) and 0.1% formic acid in CTGTGTGTTTCCAAGAGAAGTTAC  TGCATCAATTTCCTCCTGCAG  298  60  45  AF182273  CYP3A5  CTCTCTGTTTCCAAAAGATACC  TGAAGATTATTGACTGGGCTG  194  60  45  NM_000777  CYP3A7  AGATTTAATCCATTAGATCCATTCG  AGGCGACCTTCTTTTATCTG  148  60  45  AF315325  GAPDH  GAGTCAACGGATTTGGTCGT  GACAAGCTTCCCGTTCTCAG  185  60  45  BC013310 methanol (2%). Metabolites were analyzed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Instrument An Agilent 1100 series HPLC system (Agilent Technologies, Waldbronn, Germany) consisting of a binary pump, a degasser linked to a CTC HTS PAL new wash system autosampler (AMR Inc., Tokyo, Japan) was used. Mass spectrometric detection was performed on an API 4000 triple quadruple instrument (Applied Biosystems-Sciex, CA, U.S.A.) equipped with a Turbo Ion Spray ionization (ESI) interface. Data processing was performed with Analyst 1.4.2 software package (Applied Biosystems-Sciex, CA, U.S.A.).
Chromatographic Conditions The chromatographic separation was achieved on a reversed-phase CAPCELL PAK C18 MG III column (50ϫ4.6 mm i.d., 5 mm, Shiseido Co., Inc., Tokyo, Japan). The column temperature was kept constant at 40°C. The mobile phase consisted of a mixture of 10 mM ammonium acetate in water (A) with 0.1% formic acid in methanol (B) and was delivered at a flow-rate of 0.5 ml/min. A step-wise gradient of B into A was run as shown in Table 2 .
Mass Spectrometric Conditions The mass spectrometer was operated using ESI source in the positive ion detection. In order to optimize all the MS parameters, standard solutions (100 ng/ml) and internal standard were infused into the mass spectrometer at a flow-rate of 250 ml/min. The ion spray voltage (IS) was set at 4500 V. The turbo ion spray probe temperature was maintained at 600°C. The instrument parameters viz., nebulizer gas, curtain gas, auxillary gas and collision gas were set at 60, 15, 80 and 5, respectively. Compounds parameters viz., declustering potential, collision energy, entrance potential and collision exit potential were 80, 25, 10 and 15, respectively, for 6b-hydroxytestsosterone and ethoxyresorufin. Zero air was used as source gas while nitrogen was used as both curtain and collision gas. The mass spectrometer was operated at ESI positive ion mode and detection of the ions was performed in the multiple reaction monitoring (MRM) mode, monitoring the transition of m/z 305 precursor ion [MϩH] ϩ to the m/z 270 product ion for 6b-hydroxytestosterone (retention time; 6.8 min) and m/z 242 precursor ion [MϩH] ϩ to the m/z 158 product ion for ethoxyresorufin (7.4 min). Quadrupoles Q1 and Q3 were set on unit resolution. Data acquisition and quantitation were performed using analyst software version 1.4.2 (Applied Biosystems, MDSSciex, Toronto, Canada).
Calibration Standards Calibration standards to cover the assay range of 1-5000 nM of 6b-hydroxytestosterone were prepared by adding 50 ml of 0.01, 0.05, 0.1, 0.5, 1, 5, 10 and 50 mM working standards to 0.5 ml aliquots of control reaction mixture.
Statistical Analysis Statistical differences were determined by two-sided Student's t-test. Difference with pϽ0.05 was considered significant.
RESULTS
Demographic Data
Demographic data, including medication and smoking status of 20 women before term normal delivery or Caesarean section, are shown in Table 3 . Normal delivery and Caesarean section were 5 and 15 subjects, re- spectively. Thirteen women were not treated with any drugs at least last one month before labor. All women have not smoked at least last one month before labor. Real-Time RT-PCR Analysis of CYP3A4, CYP3A5 and CYP3A7 Gene Expression Expression levels of CYP3A4, CYP3A5 and CYP3A7 mRNAs in placenta, amnion and chorion/decidua were determined by quantitative real-time RT-PCR. These CYP3A mRNAs were expressed in amnion and chorion/decidua together with placenta, although the expression level of these mRNAs was strikingly different between subjects (Fig. 1) . The means of expression levels of CYP3A4, CYP3A5 and CYP3A7 mRNAs in these tissues are shown in Fig. 2 . The expression level of CYP3A4 mRNA in the placenta was about 2-fold higher than that in amnion and chorion/decidua. On the other hand, the expression levels of CYP3A5 mRNA in amnion and chorion/decidua were about 2-and 10-fold, respectively, higher than that in placenta. The expression level of CYP3A7 mRNA was highest in chorion/decidua and the level was about 3-fold of placenta and amnion.
Western Blot Analysis of CYP3A To determine whether CYP3As protein was expressed, we used the homogenates of human placenta, amnion and chorion/decidua for Western blot analysis. The immunologically related protein(s) with CYP3A7 was detected at the same mobility to CYP3A7 in all tissues examined (Fig. 3) . The content of this protein(s) in amnion was slightly lower than those in placenta and chorion/decidua.
Testosterone 6b b-Hydroxylase Activity Testosterone 6b-hydroxylase activity as a marker of CYP3A, especially CYP3A4, was determined (Fig. 4) . The activities in the homogenates of human placenta, amnion and chorion/decidua were 26.6, 3.7 and 4.6 pmol/h/mg protein, respectively. Testosterone 6b-hydroxylase activity of amnion or chorion/ decidua was significantly lower than that of placenta.
DISCUSSION
Pregnant women are exposed to a wide variety of foreign chemicals. This exposure is most commonly due to maternal medication, lifestyle factors, such as smoking and alcohol consumption, or food sources. A number of CYP isoforms related to drug metabolism are expressed in human placenta.
9) It was thought that the fetus was dependent on the maternal capacity for drug metabolism or on the placenta to act as a "shield" against potentially harmful compounds. 26) Subsequent works have demonstrated that most xenobiotics freely cross the placenta into the fetal circulation and that the human fetal liver has a significant capacity for drug metabolism. 26) There is the possibility of recycling of drugs from amniotic fluid to the fetal circulation and their persistence in the fetus. 27) In this study, we clarified that CYP3A4, CYP3A5 and CYP3A7 mRNAs were also expressed in human amnion and chorion/decidua, not only in the placenta, although the expression levels of these CYP3A mRNAs were markedly different among individuals (Fig. 1) .
Seven out of 20 pregnant women were treated with medicines such as synthetic and natural glucocorticoids, some antiepileptic drugs and ritodrine hydrochloride used for suppression of preterm labor (Table 3) . We identified that ritodrine hydrochloride did not affect the expression of CYP3A mRNAs in human fetal liver cells (Maezawa K., Matsunaga T. and Ohmori S., unpublished data). On the other hand, it is well known that the expression level of CYP3A4 in liver is enhanced by treatment with various agents, such as glucocorticoids and some antiepileptic drugs. [28] [29] [30] In this study, the expression levels of CYP3A mRNAs in placenta of mother treated with glucocorticoids or antiepileptic drugs were not especially high as compared with those in placentas of mothers who were not taking medicines (Fig. 1) . Our results are consistent with previous reports, because several drug therapies including phenobarbital and phenobarbital-like inducers such as carbamazepine have failed to affect placental CYPassociated activities. 31, 32) Paakki et al. indicated that the formation of androstenedione from testosterone as the substrate, and O-deethylase activities of 7-ethoxycoumarin and 7-ethoxyresorufin were slightly decreased in the glucocorticoid-treated patients compared to control patients' values. 33) The expression of CYP3A4 mRNA is regulated by a number of nuclear receptors, including pregnane X receptor (PXR), constitutive androstane receptor (CAR), vitamin D receptor (VDR), glucocorticoid receptor (GR), hepatocytes nuclear factor 4a (HNF4a) and farnesoid X receptor. 34, 35) CYP3A5 and CYP3A7 are transactivated by PXR and CAR. 36, 37) PXR and HNF4a determine basal hepatic expression of CYP3A4 and CYP3A5. 38, 39) The xenobiotic-induced transcriptional regulation of CYPs in human extrahepatic tissues is different from liver. 40) GR and VDR, but not PXR, are expressed in both placental syncytiotrophoblast and cytotrophoblast. 41, 42) Pavek et al. reported that expression of CYP3A4 mRNA in placenta trophoblast cell line JEG3 cells was not changed significantly after treatment with dexamethasone. 42) They also indicated that non-responsiveness of CYP3A4 promoter to glucocorticoids is responsible for low expression of HNF4a because CYP3A4 promoter was activated in placenta cells only after co-transfection with HNF4a.
42) The expression of CYP3A mRNA in placenta might be hard to be induced by various chemicals including drugs.
Western blot analysis was also performed to assess CYP3A expression in amnion, chorion/decidua and placenta at the protein level. Immunological related proteins to antibody raised against human CYP3A7 were detected in all tissues examined (Fig. 3) . The content in amnions was slightly lower than that of placenta or chorion/decidua. CYP3A4, CYP3A5 and CYP3A7 cannot be distinguished from each other by the polyclonal antibody used in this experiment. Furthermore, these CYP3A isoforms were difficult to electrophoretically separate using SDS-PAGE. These findings indicate that the bands of Western blot indicate the total amount of CYP3A isoforms. The antibody also reacted with proteins that have higher molecular weight as compared with the cDNA-expressed CYP3A7. We do not know what the immunologically related proteins are.
In the present study, 6b-hydroxytestosterone was detected as a major metabolite of testosterone in reaction mixture of amnion, chorion/decidua and placenta homogenates when the metabolites were analyzed by LC-MS/MS, as described in Materials and Methods. According to these findings, it was clarified that CYP3A isoforms in these tissues have functions. The activity in placenta was about 6-fold higher than that in amnion and chorion/decidua (Fig. 4) . These results are consistent with expression pattern of CYP3A4 mRNA in these tissues, but not CYP3A5 and CYP3A7. CYP3A4, CYP3A5 and CYP3A7 actively catalyzed testosterone 6b-hydroxylation, however, with different velocities among the isoforms. [43] [44] [45] In the previous study, Ohmori et al. clearly indicated that the rate of the reaction catalyzed by CYP3A4 was about 6-fold higher than that catalyzed by CYP3A5 or CYP3A7. 43) These results indicate that CYP3A4 is a major isoform responsible for testosterone 6b-hydroxylase activity in amnion, chorion/decidua and placenta.
CYP3A isoforms have broad substrate specificity and are responsible for the oxidative metabolism of more than 50% of clinically used drugs. 46) Our results suggested that CYP3As in fetal membranes (amnion and chorion/decidua) have the metabolic function to protect the fetus from exposure to drugs that transfer from the maternal side to the placenta, and entry into amniotic fluid via uterus. However, further studies are needed to conclude whether CYP3A isoforms are also functionally active in vivo and have con- The results are presented as the meansϮS.E. of 5 samples (number: #1, 7, 10, 12 and 15). Statistical significance of differences between testosterone 6b-hydroxylase activity in homogenate of placenta and that of amnion or chorion/decidua ( * pϽ0.05).
sequences to the maintenance of integrity of the maternalfetal barrier in the in vivo situation.
